R&D and Innovation

First-in-class internal clinical team accelerating trial progress
Identify potential targets

Experienced clinical team focus on high potential targets

Obtain future market-leading drugs
through in-house R&D or licensed in assets

Team collaboration

Global Clinical Operation

Department of Clinical Research

Department of Medicine

BDM data analysis

Department of Registration

CRO: Tigermed, Covance, etc.

Lean trial execution

Reasonable and efficient trial planning

Forward-looking design & parallel actions: start the next phase of the process based on anticipation to reduce the total duration

Efficient clinical progress

Envafolimab from Phase I to NDA only takes less than 4 years

Carrying out clinical trials throughout China and the rest of the world, partnering with top PIs to advance the R&D process
  • Professor QIN Shukui
    People's Liberation Army No.81 Hospital
  • Professor SHEN Lin
    Beijing Cancer Hospital
  • Professor LI Jin
    Shanghai East Hospital (PuDong)
Toshio Shimizu MD, PhD
National Cancer Center, Japan
Wael A. Harb MD, CPI
Purdue University
  • 70+ cooperative hospitals

  • 20+ covered provinces

  • 82+ renowned PIs